The Translational Systems Biology Symposium: New Computational Technologies and Trial Designs for a Continuum of Personalized Therapy was held on August 24-25, 2023. It focused on utilizing patient clinical and -omic data with systems biology models in clinical settings.
Advances in translational oncology using systems biology approaches have been significant in recent years. To take full advantage of these advancements for the benefit of patients, the symposium explored building innovative and streamlined clinical trials for incorporating biomarkers and new drug treatment strategies into clinical practice.
Attendees examined the areas of medicine that have the greatest potential to implement systems biology methods in the near future. They discussed plans for building the necessary clinical trial infrastructure across the nation to reduce barriers to entry of these methods and result in democratization of data and resources. Opportunities for collaboration between research institutes, pharmaceutical/biotech companies, NCI, ARPA-H, and foundations were also explored.
The meeting has led to the development of action items to facilitate the integration of systems biology into clinical trials in a manner that is efficient, accessible to research and clinical communities, and quickly benefits patients.
Documents from the Workshop
Social Media Related to the Symposium
Social media posts related to the meeting can be found using #TranslationalSysBio.
DCB Contact for the Symposium
For additional information about the Translational Systems Biology Symposium, please contact Dr. Jennifer Couch.